Effects on erythropoiesis of alemtuzumab-containing reduced intensity and standard conditioning regimens

British Journal of Haematology

Volumn 142, Issue 3, 2008, Pages 444-452

  Mijovic, Aleksandar ^a,b   Abdallah, Atiyeh ^b   Pearce, Laurence ^a   Tobal, Khalid ^a   Mufti, Ghulam J ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

ABO incompatibility; Alemtuzumab; Immune mediated anaemia; Red cell transfusion; Reduced intensity conditioning

Indexed keywords

ALEMTUZUMAB;

ADULT; AGED; ALLOGRAFT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW HYPOPLASIA; BURST FORMING UNIT; CELL TRANSPLANTATION; CONTROLLED STUDY; ERYTHROCYTE APLASIA; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HEMOLYSIS; HUMAN; HUMAN TISSUE; IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; CHIMERA; ERYTHROCYTE TRANSFUSION; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; FOLLOW-UP STUDIES; HEMAGGLUTININS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MIDDLE AGED; PROSPECTIVE STUDIES; RETICULOCYTE COUNT; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 46949087285     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07211.x     Document Type: Article

References (30)

1. Alizadeh, M., Bernard, M., Danic, B., Dauriac, C., Birebent, B., Lapart, C., Lamy, T., Le Prise, P.Y., Beauplet, A., Bories, D., Semana, G. Quelvennec, E. (2002) Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood, 99, 4618 4625.
2. Bai, L., Deng, Y.M., Dodds, A.J., Milliken, S., Moore, J. Ma, D.D. (2006) A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients. European Journal of Haematology, 77, 425 431.
3. Baron, F. Beguin, Y. (2002) Nonmyeloablative allogeneic hematopoietic stem cell transplantation. Journal of Hematotherapy and Stem Cell Research, 11, 243 263.
4. Bolan, C.D., Leitman, S.F., Griffith, L.M., Wesley, R.A., Procter, J.L., Stroncek, D.F., Barrett, A.J. Childs, R.W. (2001) Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood, 98, 1687 1694.
5. Chen, F.E., Owen, I., Savage, D., Roberts, I., Apperley, J., Goldman, J.M. Laffan, M. (1997) Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplantation, 19, 491 495.
6. Childs, R., Clave, E., Contentin, N., Jayasekera, D., Hensel, N., Leitman, S., Read, E.J., Carter, C., Bahceci, E., Young, N.S. Barrett, A.J. (1999) Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood, 94, 3234 3241.
7. Cull, G.M., Haynes, A.P., Byrne, J.L., Carter, G.I., Miflin, G., Rebello, P., Hale, G., Waldmann, H. Russell, N.H. (2000) Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity. British Journal of Haematology, 108, 754 760.
8. Cwynarski, K., Goulding, R., Pocock, C., Dazzi, F., Craddock, C., Kaeda, J., Olavarria, E., Kanfer, E., Apperley, J., Lawler, M. Goldman, J.M. (2001) Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions. Bone Marrow Transplantation, 28, 581 586.
9. Erker, C.G., Steins, M.B., Fischer, R.J., Kienast, J., Berdel, W.E., Sibrowski, W. Cassens, U. (2005) The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion, 45, 1382 1390.
10. Gajewski, J.L., Petz, L.D., Calhoun, L., O'Rourke, S., Landaw, E.M., Lyddane, N.R., Hunt, L.A., Schiller, G.J., Ho, W.G. Champlin, R.E. (1992) Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood, 79, 3076 3085.
11. Giralt, S., Thall, P.F., Khouri, I., Wang, X., Braunschweig, I., Ippolitti, C., Claxton, D., Donato, M., Bruton, J., Cohen, A., Davis, M., Andersson, B.S., Anderlini, P., Gajewski, J., Kornblau, S., Andreeff, M., Przepiorka, D., Ueno, N.T., Molldrem, J. Champlin, R. (2001) Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood, 97, 631 637.
12. Hows, J., Beddow, K., Gordon-Smith, E., Branch, D.R., Spruce, W., Sniecinski, I., Krance, R.A. Petz, L.D. (1986) Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood, 67, 177 181.
13. Kanda, Y., Tanosaki, R., Nakai, K., Saito, T., Ohnishi, M., Niiya, H., Chizuka, A., Yakushijin, K., Urahama, N., Ueda, K., Iijima, K., Ando, T., Matsubara, H., Kami, M., Makimoto, A., Kobayashi, Y., Tobinai, K., Mineishi, S. Takaue, Y. (2002) Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor. British Journal of Haematology, 118, 128 131.
14. Klangsinsirikul, P., Carter, G.I., Byrne, J.L., Hale, G. Russell, N.H. (2002) Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood, 99, 2586 2591.
15. Lapierre, V., Oubouzar, N., Auperin, A., Tramalloni, D., Tayebi, H., Robinet, E., Kuentz, M., Blaise, D., Hartmann, O., Herve, P. Tiberghien, P. (2001) Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation. Blood, 97, 2580 2586.
16. Lee, J.H., Lee, J.H., Choi, S.J., Kim, S., Seol, M., Kwon, S.W., Park, C.J., Chi, H.S., Lee, J.S., Kim, W.K. Lee, K.H. (2003) Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation. British Journal of Haematology, 120, 702 710.
17. Loh, Y., Oyama, Y., Statkute, L., Quigley, K., Yaung, K., Gonda, E., Barr, W., Jovanovic, B., Craig, R., Stefoski, D., Cohen, B. Burt, R.K. (2007) Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used. Blood, 109, 2643 2648.
18. Maciej Zaucha, J., Mielcarek, M., Takatu, A., Little, M.T., Gooley, T., Baker, J., Maloney, D.G., Sandmaier, B.M., Maris, M., Chauncey, T., Storb, R. Torok-Storb, B. (2002) Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. British Journal of Haematology, 119, 740 750.
19. Matsue, K., Yasue, S., Matsuda, T., Iwabuchi, K., Ohtsuka, M., Ueda, M., Kondo, K., Shiobara, S., Mori, T. Koizumi, S. (1989) Plasma glycosyltransferase activity after ABO-incompatible bone marrow transplantation and development of an inhibitor for glycosyltransferase activity. Experimental Haematology, 17, 827 831.
20. Mielcarek, M., Leisenring, W., Torok-Storb, B. Storb, R. (2000) Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood, 96, 1150 1156.
21. Mijovic, A., Fishlock, K., Pagliuca, A. Mufti, G.J. (1998) Blast counts in blood progenitor cell (BPC) correlate with CD34 + cells and CFU-GM and are useful predictor of haemopoietic recovery after autologous BPC transplantation collections. Bone Marrow Transplantation, 21, 869 872.
22. Montero, A., Savani, B.N., Kurlander, R., Read, E.J., Leitman, S.F., Childs, R., Solomon, S.R. Barrett, A.J. (2005) Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. British Journal of Haematology, 130, 733 739.
23. Peggs, K.S., Morris, E.C., Kottaridis, P.D., Geary, J., Goldstone, A.H., Linch, D.C. Mackinnon, S. (2002) Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen. Blood, 99, 4642 4643.
24. Petz, L.D. Garratty, G 2004) Immune Haemolysis Associated with Transplantation. Immune Haemolytic Anemias, pp. 459 516. Churchill Livingstone, Alemtuzumab.
25. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. Thomas, E.D. (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplantation, 15, 825 828.
26. Snell, M., Chau, C., Hendrix, D., Fox, R., Downes, K.A., Creger, R., Meyerson, H., Telen, M.J., Laughlin, M.J., Lazarus, H.M. Yomtovian, R. (2006) Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation. Bone Marrow Transplantation, 38, 135 140.
27. Sniecinski, I., O'Donnell, M.R., Nowicki, B. Hill, L.R. (1988) Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood, 71, 1402 1407.
28. Weissinger, F., Sandmaier, B.M., Maloney, D.G., Bensinger, W.I., Gooley, T. Storb, R. (2001) Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. Blood, 98, 3584 3588.
29. Worel, N., Greinix, H.T., Keil, F., Mitterbauer, M., Lechner, K., Fischer, G., Mayr, W., Hocker, P. Kalhs, P. (2002) Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion, 42, 1293 1301.
30. Worel, N., Kalhs, P., Keil, F., Prinz, E., Moser, K., Schulenburg, A., Mitterbauer, M., Mannhalter, C., Mayr, W.R., Schwarzinger, I., Hocker, P., Lechner, K. Greinix, H.T. (2003) ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion, 43, 1153 1161.